ClinicalTrials.Veeva

Menu

Dat'Aids Prevention

D

DatAids

Status

Enrolling

Conditions

HIV Prevention

Study type

Observational

Funder types

Other

Identifiers

NCT03795376
DAT_002

Details and patient eligibility

About

DatAIDS prevention is a cohort study of HIV prevention in over 23 HIV sites in France including overseas, aiming to describe HIV prevention in every aspect including HIV screening, STI and hepatitis screening, post-exposure prophylaxis and pre-exposure prophylaxis

Enrollment

6,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female over 18 years old,
  • HIV negative
  • Attending for :
  • HIV screening
  • Hepatitis screening
  • STI screening / treatment
  • Blood, body fluid or sexual exposure
  • Post-exposure prophylaxis
  • Pre-exposure prophylaxis
  • Signed consent

Exclusion criteria

  • HIV-infection
  • Refusal to participate

Trial contacts and locations

31

Loading...

Central trial contact

Solène Secher; Pascal Pugliese, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems